Clinical Trials

 

Nanodiamonds and Antibiotics Modified Gutta-percha (NDGX) for Non-surgical Root Canal Therapy (RCT) Filler Material

Intervention Type: Device, Combination Product
Study Type: Interventional
Sponsors: University of California, Los Angeles
Participants: 54
Authors
Mo K Kang, Dean Ho, Eric C Sung, Daniel Choi, Theodore W Kee, Dong-Keun Lee
Abstract
The purpose of this study is to to compare root canal therapy success between two root canal filler materials: 1) gutta percha (GP), 2) gutta percha modified with nanodiamonds and amoxicillin (NDGX). Gutta percha is the current standard root canal filler material used during non-surgical root canal therapy (RCT). Gutta percha modified with nanodiamonds and amoxicillin is an investigational root canal filler material, not yet FDA approved for use as described in this study. The safety and usefulness of NDGX is being tested in this study in comparison to the current standard of care, gutta percha (GP).
* Consult with your doctor before enrolling in clinical trials.
Facilities
University of California, Los Angeles - Recruiting
Los Angeles, United States of America
Contacts
Backup
Eric C Sung, D.D.S.
esung@dentistry.ucla.edu
(310) 206-6259
Primary
Mo K Kang, Ph.D,D.D.S.
mkang@dentistry.ucla.edu
(310) 825-8048
Eligibilities
Sex: All
Minimum Age: 18
Healthy Volunteers: No
Inclusion Criteria:
- All of the patients must be over 18 years of age and in need of non-surgical RCT treatment during the consultation visit.
Exclusion Criteria:
- Molar teeth
- Osteoporosis medication or i.v. bisphosphonates
- Dental material allergies
- Allergic to penicillin and/or amoxicillin
- Have MD consult/medically compromised/prophylaxis needed
Relevant Conditions

Gangrene, Necrosis

View Article From Source